Savara Inc - Asset Resilience Ratio

Latest as of June 2026: 68.30%

Savara Inc (SVRA) has an Asset Resilience Ratio of 68.30% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Savara Inc (SVRA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

$131.23 Million

Cash + Short-term Investments

Total Assets

$192.14 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how Savara Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Savara Inc (SVRA) total assets.

Liquid Assets Composition Over Time

This chart breaks down Savara Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Savara Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$131.23 Million	68.3%
Total Liquid Assets	$131.23 Million	68.30%

Asset Resilience Insights

Very High Liquidity: Savara Inc maintains exceptional liquid asset reserves at 68.30% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Savara Inc Industry Peers by Asset Resilience Ratio

Compare Savara Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Aurinia Pharmaceuticals Inc NASDAQ:AUPH	Biotechnology	33.23%
Nanobiotix NASDAQ:NBTX	Biotechnology	4.71%
Innovita Biological Technology Co. Ltd. A SHG:688253	Biotechnology	65.12%

Annual Asset Resilience Ratio for Savara Inc (2005–2025)

The table below shows the annual Asset Resilience Ratio data for Savara Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	79.91%	$202.52 Million	$253.44 Million	-5.21pp
2024-12-31	85.12%	$181.20 Million	$212.88 Million	+8.68pp
2023-12-31	76.44%	$135.73 Million	$177.56 Million	+23.66pp
2022-12-31	52.78%	$73.78 Million	$139.78 Million	-19.22pp
2021-12-31	72.00%	$127.16 Million	$176.60 Million	+11.33pp
2020-12-31	60.68%	$59.31 Million	$97.75 Million	+7.85pp
2019-12-31	52.83%	$71.96 Million	$136.20 Million	-3.99pp
2018-12-31	56.82%	$86.53 Million	$152.29 Million	+11.59pp
2017-12-31	45.23%	$72.19 Million	$159.63 Million	+35.76pp
2016-12-31	9.47%	$2.74 Million	$28.93 Million	-23.60pp
2015-12-31	33.07%	$17.93 Million	$54.22 Million	+2.60pp
2014-12-31	30.47%	$21.48 Million	$70.50 Million	-3.40pp
2013-12-31	33.87%	$18.71 Million	$55.25 Million	+4.04pp
2012-12-31	29.83%	$14.01 Million	$46.97 Million	+18.30pp
2011-12-31	11.53%	$7.13 Million	$61.86 Million	-42.55pp
2007-12-31	54.09%	$18.68 Million	$34.54 Million	+5.28pp
2006-12-31	48.81%	$25.77 Million	$52.80 Million	+15.12pp
2005-12-31	33.69%	$7.96 Million	$23.62 Million	--

pp = percentage points

About Savara Inc

NASDAQ:SVRA USA Biotechnology

Market Cap

$1.08 Billion

Market Cap Rank

#8535 Global

#2473 in USA

Share Price

$5.26

Change (1 day)

-1.50%

52-Week Range

$3.37 - $6.94

All Time High

$45.57